ÂÜÀòÂÒÂ×

Rebecca Paul is a seasoned expert in medicinal drug design and drug discovery, currently serving as the Head of Medicinal Drug Design and Senior Research Leader at Isomorphic Labs since October 2022. Prior to this role, Rebecca held various senior positions at BenevolentAI from January 2019 to October 2022, including Senior Principal Scientist and Principal Scientist. Rebecca began their career at Heptares, where roles included Senior Scientist and Industrial Post-Doctoral Scientist from November 2012 to January 2019. Academically, Rebecca earned a Doctor of Philosophy (PhD) in chemical biology and a Master of Research (MRes) in Chemical Biology from Imperial College London, and a Master of Arts (MA) in Natural Sciences from the University of Cambridge.